IGF2BP3 and carcinoma: Lochhead et al. revealed that normal colorectal epithelium was negative for IGF2BP3 in patients of normal mucosa adjacent to carcinoma, and IGF2BP3 was associated with poor differentiation, stage III–IV disease, BRAF mutation, and LINE-1 hypomethylation[39].